BOTACLINIC

BOTACLINIC has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €199,172 and a net result of -€30,253. Equity is growing by about 7.5% per year across the filed financial years. Its solvency ranks better than 55% of 780 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).